RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Panion & BF Biotech Stock

Panion & BF Biotech ROCE 2024

Panion & BF Biotech ROCE

0.08

Ticker

1760.TW

ISIN

TW0001760007

In 2024, Panion & BF Biotech's return on capital employed (ROCE) was 0.08, a -60.21% increase from the 0.21 ROCE in the previous year.

Panion & BF Biotech Aktienanalyse

What does Panion & BF Biotech do?

Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Panion & BF Biotech's Return on Capital Employed (ROCE)

Panion & BF Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Panion & BF Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Panion & BF Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Panion & BF Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Panion & BF Biotech stock

What is the ROCE (Return on Capital Employed) of Panion & BF Biotech this year?

The ROCE of Panion & BF Biotech is 0.08 undefined this year.

How has the ROCE (Return on Capital Employed) of Panion & BF Biotech developed compared to the previous year?

The ROCE of Panion & BF Biotech has increased by -60.21% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Panion & BF Biotech?

A high Return on Capital Employed (ROCE) indicates that Panion & BF Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Panion & BF Biotech?

A low ROCE (Return on Capital Employed) can indicate that Panion & BF Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Panion & BF Biotech impact the company?

An increase in the ROCE of Panion & BF Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Panion & BF Biotech affect the company?

A decrease in ROCE of Panion & BF Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Panion & BF Biotech?

Some factors that can affect Panion & BF Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Panion & BF Biotech so important for investors?

The ROCE of Panion & BF Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Panion & BF Biotech take to improve the ROCE?

To improve the ROCE, Panion & BF Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Panion & BF Biotech pay?

Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.

What is the dividend yield of Panion & BF Biotech?

The current dividend yield of Panion & BF Biotech is 2.13 %.

When does Panion & BF Biotech pay dividends?

Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Panion & BF Biotech?

Panion & BF Biotech paid dividends every year for the past 10 years.

What is the dividend of Panion & BF Biotech?

For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is Panion & BF Biotech located?

Panion & BF Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Panion & BF Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Panion & BF Biotech in the year 2023?

In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.

In which currency does Panion & BF Biotech pay out the dividend?

The dividends of Panion & BF Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panion & BF Biotech

Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.